BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31808839)

  • 1. Genetic predisposition to MDS: diagnosis and management.
    Furutani E; Shimamura A
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):110-119. PubMed ID: 31808839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
    Schratz KE; DeZern AE
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):333-356. PubMed ID: 32089214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition to MDS: clinical features and clonal evolution.
    Kennedy AL; Shimamura A
    Blood; 2019 Mar; 133(10):1071-1085. PubMed ID: 30670445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
    Tawana K; Drazer MW; Churpek JE
    Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
    West AH; Godley LA; Churpek JE
    Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations in MDS/AML predisposition disorders.
    Godley LA
    Curr Opin Hematol; 2021 Mar; 28(2):86-93. PubMed ID: 33394724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical considerations for diagnosis and management of patients and carriers.
    Niemeyer CM; Mecucci C
    Semin Hematol; 2017 Apr; 54(2):69-74. PubMed ID: 28637619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline ETV6 mutations and predisposition to hematological malignancies.
    Feurstein S; Godley LA
    Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplastic anemia and clonal evolution: germ line and somatic genetics.
    Shimamura A
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
    Czuchlewski DR; Peterson LC
    Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
    Elghetany MT; Patnaik MM; Khoury JD
    Leuk Res; 2024 Feb; 137():107441. PubMed ID: 38301422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and treatment of MDS in genetically susceptible persons.
    Davies SM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):105-109. PubMed ID: 31808891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
    Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
    Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
    Padron E; Steensma DP
    Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome.
    Kennedy JA; Ebert BL
    J Clin Oncol; 2017 Mar; 35(9):968-974. PubMed ID: 28297619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.